Literature DB >> 1641990

A single amino acid substitution in the hemagglutinin-neuraminidase of Newcastle disease virus results in a protein deficient in both functions.

J P Sheehan1, R M Iorio.   

Abstract

Sequence determinations of the hemagglutinin-neuraminidase (HN) glycoproteins of a temperature-sensitive mutant of Newcastle disease virus and two sequentially selected revertants had previously shown that substitution at a pair of residues, 129 and 175, resulted in a deficiency in neuraminidase (NA) activity, which was partially restored by a third substitution at residue 193. To evaluate the role of the substitution at residue 175 in diminished NA activity, the mutation was introduced into HN and the protein expressed in COS cells. The mutated HN not only had minimal NA activity but also was unable to absorb chicken erythrocytes, even though it was transported to the cell surface in normal amounts, in an apparently antigenic form. Attachment function was restored to the protein by the introduction of the additional substitution(s) at 129 and/or 193. These results indicate that residue 175 influences not only NA activity but also receptor recognition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1641990     DOI: 10.1016/0042-6822(92)90605-o

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: identification of key amino acids involved in cell binding, catalysis, and fusion.

Authors:  Helen Connaris; Toru Takimoto; Rupert Russell; Susan Crennell; Ibrahim Moustafa; Allen Portner; Garry Taylor
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Neuraminidase-deficient Sendai virus HN mutants provide protection from homologous superinfection.

Authors:  Christine A Baumann; Wolfgang J Neubert
Journal:  Arch Virol       Date:  2009-12-19       Impact factor: 2.574

3.  Contribution of the human parainfluenza virus type 3 HN-receptor interaction to pathogenesis in vivo.

Authors:  G A Prince; M G Ottolini; A Moscona
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir).

Authors:  Matthew Murrell; Matteo Porotto; Thomas Weber; Olga Greengard; Anne Moscona
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity.

Authors:  M T Murrell; M Porotto; O Greengard; N Poltoratskaia; A Moscona
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant.

Authors:  M Porotto; O Greengard; N Poltoratskaia; M A Horga; A Moscona
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

7.  Localization of monoclonal antibody epitopes and functional domains in the hemagglutinin protein of measles virus.

Authors:  K B Hummel; W J Bellini
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

8.  Site-directed mutagenesis of a conserved hexapeptide in the paramyxovirus hemagglutinin-neuraminidase glycoprotein: effects on antigenic structure and function.

Authors:  A M Mirza; R Deng; R M Iorio
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein: receptor recognition is dependent on neuraminidase activity.

Authors:  R M Iorio; G M Field; J M Sauvron; A M Mirza; R Deng; P J Mahon; J P Langedijk
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

10.  Fusion mutants of Newcastle disease virus selected with monoclonal antibodies to the hemagglutinin-neuraminidase.

Authors:  R M Iorio; R L Glickman
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.